RedHill Biopharma (RDHL) has released an update.
RedHill Biopharma Ltd. has announced the postponement of its Annual General Meeting of Shareholders originally scheduled for September 17, 2024, due to not meeting the legal quorum requirements. The meeting has been rescheduled to take place on September 18, 2024, at the company’s offices in Israel. This information has been filed with the SEC and incorporated into the company’s existing Registration Statements.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
